 |
市場調査レポート
商品コード
950726
COVID-19向け個人用保護具 (PPE：ガウン、医療用手袋、フェイスマスク、フェイスシールド、眼球保護具) の市場 (2020年～2024年) - 年間最大910億米ドルの市場価値、5種類のサブ市場の分析COVID-19 PPE (Gowns, Medical Gloves, Face Masks, Face Shields, Eye Protection) Market 2020-2024: Market Worth up to $91 Billion per Annum, 5 Sub-reports |
||||||
Homeland Security Research Corporation (HSRC)| COVID-19向け個人用保護具 (PPE：ガウン、医療用手袋、フェイスマスク、フェイスシールド、眼球保護具) の市場 (2020年～2024年) - 年間最大910億米ドルの市場価値、5種類のサブ市場の分析 |
|
出版日: 2020年07月24日
発行: Homeland Security Research Corporation (HSRC)
ページ情報: 英文 315 Pages; 2020 Tables & Figures
納期: 即日から翌営業日
|
感染症の爆発的流行 (パンデミック) を抑えるためには個人用保護具 (PPE) が不可欠である、という認識が世界各国で浸透しつつあります。他方、世界のPPE供給量のほとんどを中国が占めているため、COVID-19感染拡大の当初は中国市場のロックダウンで世界全体の流通体制が混乱するという事態が生じました。その後も模造品の偽造が相次ぎ、中国政府の取り締まりをも受けて、同国からの製品供給が一層困難になりつつあります。
COVID-19感染拡大の緩和製品の市場規模 (2020年～2024年) のうち、PPEのシェアは全体の12％～25％を占めると見込まれています。他方、PPEの価格水準は年間15％～25％低下すると見込まれています。
当レポートでは、世界のCOVID-19向け個人用保護具 (PPE) の市場について分析し、全体的な市場規模 (処置件数) の動向見通しや、サブ市場別 (全5種類) の詳細動向、シナリオ別の将来予測、業界関係者が今後解決すべき課題、といった情報を取りまとめてお届けいたします。
The report includes an in-depth analysis of five PPE sub-reports:
It is now widely agreed upon that an essential remedy to the suppression of the pandemic is the use of Personal Protective Equipment (PPE). The ability to curb the spread of the pandemic and minimize new surges so that the economy will recover, largely depends on how well the healthcare community and governments will educate their citizens to use Personal Protection Gear, especially face masks.
According to the report, the Personal Protection Gear annual market share* will hoover at 12%-25% of the total COVID-19 Pandemic Mitigation Products Market, while PPE prices will decline by 15-25% per annum.
Currently, China manufactures the majority of the globe's PPE. During Q1 2020, as the coronavirus tore through China and it went into lockdown, Chinese PPE factories ramped up their production. As China started to re-open its economy as the pandemic continued spreading throughout the rest of the world, demand for Personal Protection Gear soared to the point that factory owners in the industry began boasting that they owned money printing machines. As orders of consumer goods shrunk, anxious manufacturers, who had the clean rooms and know-how needed to make PPE, switched their production lines over to make face masks, gloves and PPE gowns.
With demand exploding, full payment up front became the norm. Fraud and counterfeit products proliferated. In April 2020, the PRC government rolled out actions intended to clamp down on counterfeit PPE, and it became even trickier to ship products out of China. For many Chinese tech companies, swooping in as the savior is shrewd publicity. "They have the funds and the political clout, and it's good for their business mission," says J. Norwell Coquillard, executive director of the Washington State China Relations Council, a Seattle-based lobbying group helping local health-care buyers vet Chinese suppliers of PPE.
The team which composed this report brings 43 years of hands on record in the development and commercialization of healthcare products including: antibody antigen detection, E-health, decontamination and biosecurity, PACS, teleradiology, PPE, computerized tomography, medical devices and more. Our team members bring long term relations with the U.S. FDA and CDC as well as the EU CE and other national medical regulatory agencies.
To adhere to our high standards of research, as nobody can forecast the future of the pandemic, we include in the report two scenarios:
比較リスト
